Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARILUMAB vs SATRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARILUMAB vs SATRALIZUMAB: Safety Overview

Metric SARILUMAB SATRALIZUMAB
Total FAERS Reports 21,493 219
Deaths Reported 1,983 16
Death Rate 9.2% 7.3%
Hospitalizations 3,538 108
Average Patient Age 57.5 yrs 51.6 yrs
% Female Patients 84.4% 82.1%
Manufacturer Sanofi-Aventis U.S. LLC Genentech, Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription Prescription